IPO - Tevogen Bio Holdings Inc.
Form Type: 424B5
Filing Date: 2025-07-03
Corporate Action: Ipo
Type: New
Accession Number: 000164117225017863
Filing Summary: Tevogen Bio Holdings Inc. is offering common stock with an aggregate price of up to $50,000,000 through a Sales Agreement with A.G.P./Alliance Global Partners, effective July 3, 2025. The shares will be sold under an 'at-the-market offering' strategy, allowing flexible sales conditions based on market demand. A commission of 3.0% will be paid to the Agent on sales. The offering is part of a shelf registration effective since June 26, 2025. There are significant risks associated with investing in the common stock due to the company's need for substantial funding and ongoing operational challenges. The stock trades on Nasdaq under the symbol 'TVGN' and was priced at $1.25 as of July 2, 2025. Proceeds from the offering are intended for general corporate purposes including R&D and potential acquisitions, although management has discretion over their use.
Additional details:
Common Stock Offered: Shares of common stock with an aggregate offering price of up to $50,000,000
Common Stock Outstanding Post Offering: Up to 224,443,433 shares assuming 40,000,000 shares sold at $1.25
Agent Compensation: 3.0% commission on gross sales price
Nasdaq Symbol: TVGN
Risk Factors: Investing involves high risks including potential cash shortages, need for additional capital, and operational uncertainties.
Use Of Proceeds: General corporate purposes including working capital, research and development, and potential acquisitions.
Comments
No comments yet. Be the first to comment!